CN103957894A - 两相药物递送系统 - Google Patents

两相药物递送系统 Download PDF

Info

Publication number
CN103957894A
CN103957894A CN201280051084.0A CN201280051084A CN103957894A CN 103957894 A CN103957894 A CN 103957894A CN 201280051084 A CN201280051084 A CN 201280051084A CN 103957894 A CN103957894 A CN 103957894A
Authority
CN
China
Prior art keywords
hydrogel
pharmaceutical composition
coating
particles
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280051084.0A
Other languages
English (en)
Chinese (zh)
Inventor
汉斯·尤尔根·迈尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
RP Scherer Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RP Scherer Technologies LLC filed Critical RP Scherer Technologies LLC
Publication of CN103957894A publication Critical patent/CN103957894A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201280051084.0A 2011-10-19 2012-10-05 两相药物递送系统 Pending CN103957894A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161548837P 2011-10-19 2011-10-19
US61/548,837 2011-10-19
PCT/US2012/058829 WO2013058996A1 (en) 2011-10-19 2012-10-05 Two phase pharmaceutical delivery system

Publications (1)

Publication Number Publication Date
CN103957894A true CN103957894A (zh) 2014-07-30

Family

ID=48135086

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280051084.0A Pending CN103957894A (zh) 2011-10-19 2012-10-05 两相药物递送系统

Country Status (9)

Country Link
US (1) US9314441B2 (https=)
EP (1) EP2768488A4 (https=)
JP (1) JP2014530855A (https=)
CN (1) CN103957894A (https=)
AR (1) AR088369A1 (https=)
AU (1) AU2012326513B2 (https=)
BR (1) BR112014009547A8 (https=)
CA (1) CA2852447A1 (https=)
WO (1) WO2013058996A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021102260A1 (en) * 2019-11-22 2021-05-27 Emanate Biomedical Inc. Oral appliance for delivery of an antimicrobial composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3419657A (en) 1964-06-23 1968-12-31 Dagra Nv Iodopanoic acid in a hydrogel
US4837255A (en) 1987-03-10 1989-06-06 Ciba-Geigy Corporation Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
JPH04149716A (ja) * 1990-10-15 1992-05-22 Fujitsu Ltd 情報処理装置
RU2113220C1 (ru) * 1991-07-24 1998-06-20 Энзакор Пропертиз Лимитед Композиция, способ лечения кишечной инфекции, способ неспецифической стимуляции имvунной системы, способ доставки биологически активного материала в верхние отделы тонкого кишечника
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
IL108366A (en) 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
IT1273742B (it) * 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
DE19529862A1 (de) 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US6365180B1 (en) 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
US6071523A (en) 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
CA2243619A1 (fr) 1998-07-17 2000-01-17 Universite De Sherbrooke Hydrogels polyioniques a base de xanthane et chitosane pour stabilisation et relargage controle des vitamines
CA2345779A1 (en) * 1999-08-27 2001-03-08 Department Of National Defence Hydrogel wound dressing containing liposome-encapsulated therapeutic agent
DE10224086A1 (de) 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
CA2490142A1 (en) * 2002-07-03 2004-01-15 Abbott Laboratories Liquid dosage forms of proton pump inhibitors
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US20040265359A1 (en) 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine
US20080226705A1 (en) 2004-03-31 2008-09-18 Soltero Richard A Gel delivery system for oral administration of medicaments
DK1758557T3 (da) * 2004-05-11 2011-10-24 Egalet Ltd Kvældbar doseringsform omfattende gellangummi
WO2007001448A2 (en) * 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
JP4987261B2 (ja) 2005-07-13 2012-07-25 株式会社 メドレックス ゲル状経口製剤
DOP2006000274A (es) 2005-12-14 2007-10-15 Sanofi Aventis Us Llc Formulación de suspensión de fexofenadina
JP2007252341A (ja) * 2006-03-24 2007-10-04 Well Haamonii:Kk 粉末嚥下補助食品
JP2008125435A (ja) * 2006-11-21 2008-06-05 Well Haamonii:Kk ゲル形成性組成物及びこの組成物を含有するゲル
US20080171110A1 (en) * 2007-01-17 2008-07-17 Geoffrey Catherwood Stuart Solids package
JP2009007262A (ja) * 2007-06-26 2009-01-15 Toyo Capsule Kk ビスホスホネート製剤
JP5320091B2 (ja) * 2009-02-02 2013-10-23 大蔵製薬株式会社 医薬成分が長期安定化された経口投与医薬ゼリー製剤
EP2717685B1 (en) * 2011-06-07 2018-08-22 Gelesis LLC Method for producing hydrogels

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier

Also Published As

Publication number Publication date
AU2012326513A1 (en) 2014-05-01
CA2852447A1 (en) 2013-04-25
WO2013058996A1 (en) 2013-04-25
EP2768488A1 (en) 2014-08-27
US9314441B2 (en) 2016-04-19
JP2014530855A (ja) 2014-11-20
AR088369A1 (es) 2014-05-28
BR112014009547A2 (pt) 2017-04-18
AU2012326513B2 (en) 2016-03-17
BR112014009547A8 (pt) 2018-01-23
EP2768488A4 (en) 2015-04-15
US20130098797A1 (en) 2013-04-25

Similar Documents

Publication Publication Date Title
Nayak et al. Drug delivery: Present, past, and future of medicine
ES2226137T3 (es) Microesfera de retencion gastrica controlada para mejorar la administracion de los medicamentos.
Nayak et al. Current developments in orally disintegrating tablet technology
ES2444951T3 (es) Películas uniformes para una forma farmacéutica de disolución rápida que incorpora composiciones de enmascaramiento del sabor
CN102000042B (zh) 控释制剂
JPWO2003043609A1 (ja) 非ゼラチン系カプセル皮膜組成物及びそれを用いたカプセル
CN101677967A (zh) 调释固体或半固体剂型
CN113490486B (zh) 最小化团聚、曝气和保持包含布洛芬的药物组合物的包衣
CN101325948A (zh) 具有亲水稳定层的组合物和胶囊
JP7681511B2 (ja) インライン混合中の懸濁液の通気の最小化
JP2009543791A (ja) 即放性形態および徐放性形態のトラマドールを有するマルチパーティキュレート処方物
WO2005102291A1 (ja) 水溶性活性成分含有シームレスカプセル
TW200800305A (en) Encapsulation of lipid-based formulations in enteric polymers
CN103957894A (zh) 两相药物递送系统
TW201707691A (zh) 口溶膜
Gupta et al. An overview of novel techniques employed in mouth dissolving drug delivery system
ES2351067T3 (es) Composiciones farmacéuticas fáciles de tragar, que no provocan una sensación desagradable en la boca y que comprenden partículas con un ingrediente activo.
Sayyad et al. A review on formulation of conventional drug delivery system and novel drug delivery system
Parveen et al. Fast Dissolving Tablets Using Natural Polymers: A Comprehensive Review on Formulation Strategies, Mechanisms, and Future Prospects
RU2842481C1 (ru) Фармацевтические композиции, содержащие покрытый api
Ghatole et al. Taste masking polymers
JP2015000867A (ja) 薬物内包粒子及びそれを含有する医薬製剤
Zangi et al. Recent Advances in Wafer Delivery: Chemistry, Manufacturing, and Control
US20260060924A1 (en) Semi-solid oral dosage form with encapsulated active ingredient
HK40091698A (zh) 包含经包衣api的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140730